Form 4: Cue Biopharma CEO Sells Shares
Insider Transaction (Form 4)
Shao-Lee Lin, Chief Executive Officer and a Director of Cue Biopharma, Inc., sold 11,087 shares of common stock on October 12, 2026.
Summary
- Open-market sale: disposed of 10,000 Common Stock at $27.50 ($275,000) on October 12, 2026; holds 695,995 after (Direct).
- Open-market sale: disposed of 1,087 Common Stock at $28.05 ($30,490) on October 12, 2026; holds 694,908 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $305,490 of stock on the open market.
Insider Transactions
Shao-Lee Lin — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-12 | Open-market sale | Common Stock | 10,000 | $28 | $275.0K | 695,995 |
| 2026-10-12 | Open-market sale | Common Stock | 1,087 | $28 | $30.5K | 694,908 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-12 | Open-market sale (10,000 shares) |
| 2026-10-12 | Open-market sale (1,087 shares) |
Keywords
insider transaction, Form 4, CUE, Cue Biopharma, Inc., bearish, Shao-Lee Lin
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.